Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia
dc.contributor.author | Thornburg, C. D. | en_US |
dc.contributor.author | Pipe, Steven W. | en_US |
dc.date.accessioned | 2010-06-01T21:13:07Z | |
dc.date.available | 2010-06-01T21:13:07Z | |
dc.date.issued | 2006-03 | en_US |
dc.identifier.citation | THORNBURG, C. D.; PIPE, S. W. (2006). "Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia." Haemophilia 12(2): 198-199. <http://hdl.handle.net/2027.42/74297> | en_US |
dc.identifier.issn | 1351-8216 | en_US |
dc.identifier.issn | 1365-2516 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74297 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16476098&dopt=citation | en_US |
dc.format.extent | 56471 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 2006 Blackwell Publishing Ltd | en_US |
dc.title | Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 16476098 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74297/1/j.1365-2516.2006.01172.x.pdf | |
dc.identifier.doi | 10.1111/j.1365-2516.2006.01172.x | en_US |
dc.identifier.source | Haemophilia | en_US |
dc.identifier.citedreference | Berntorp E, Boulyjenkov V, Brettler D et al. Modern treatment of haemophilia. Bull World Health Organ 1995; 73: 691 – 701. | en_US |
dc.identifier.citedreference | 2 Medical and Scientific Advisory Council. MASAC Recommendations Concerning Prophylaxis Medical Bulletin no. 193 (Chapter Advisory 197). 1994. | en_US |
dc.identifier.citedreference | Shapiro AD. Why is primary prophylaxis underutilized in the United States ? Haemophilia 2003; 9: 670 – 2. | en_US |
dc.identifier.citedreference | Blanchette VS, McCready M, Achonu C, Abdolell M, Rivard G, Manco-Johnson MJ. A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres. Haemophilia 2003; 9 ( Suppl. 1 ): 19 – 26. | en_US |
dc.identifier.citedreference | Schramm W, Berger K. Economics of prophylactic treatment. Haemophilia 2003; 9 ( Suppl. 1 ): 111 – 5. | en_US |
dc.identifier.citedreference | Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia 2001; 7: 392 – 6. | en_US |
dc.identifier.citedreference | Becker MH, Maiman LA, Kirscht JP, Haefner DP, Drachman RH, Taylor DW. Patient perceptions and compliance: recent studies of the health belief model. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, MD: The Johns Hopkins University Press, 1979: 78 – 109. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.